"This acquisition will provide Health Dialog with an expanded footprint to grow its existing business, as well as further leverage the company's coaching services' expertise, as we work to bring Rite Aid Health Alliance to more Rite Aid markets and customers,” Rite Aid chairman and CEO John Standley said in a statement. “Additionally, we will benefit from Health Dialog's industry-leading analytics and shared-decision making tools, helping us to better serve the health and wellness needs of our customers and further develop our pharmacy services as a growing retail healthcare company.”
Rite Aid Health Alliance is being offered to patients whose physicians recommend they participate in pilot programs at several Rite Aid pharmacies in Buffalo, N.Y., Greensboro, N.C., and the greater Los Angeles area. Pilot programs will involve pharmacists and coaches working with patients dealing with such chronic and poly-chronic conditions as congestive heart failure, chronic obstructive pulmonary disease, high cholesterol and diabetes.
The market responded favorably to the deal, with Rite Aid stock rising after its announcement Tuesday. The chain's common shares were up fractionally to $6.39 a share this morning.
Follow John N. Frank on Twitter: @MHJFrank
